Volume 11 Issue 1
Jan.  2020
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2020  >  11(1): 8-12
Lyu Ling, Ni Xuhao. Individualized induction of immune tolerance and regulatory T cell[J]. ORGAN TRANSPLANTATION, 2020, 11(1): 8-12. doi: 10.3969/j.issn.1674-7445.2020.01.002
Citation: Lyu Ling, Ni Xuhao. Individualized induction of immune tolerance and regulatory T cell[J]. ORGAN TRANSPLANTATION, 2020, 11(1): 8-12. doi: 10.3969/j.issn.1674-7445.2020.01.002
shu

Individualized induction of immune tolerance and regulatory T cell

doi: 10.3969/j.issn.1674-7445.2020.01.002

  • Hepatobiliary Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210009, China

More Information
  • Corresponding author: Lyu Ling, Email:lvling@njmu.edu.cn
  • Received Date: 2019-10-12
    Available Online: 2021-01-19
  • Publish Date: 2020-01-15
    Abstract
  • The induction of immune tolerance is an essential component and the utmost goal in the field of organ transplantation immunity, which depends upon the recognition and presentation of transplantation antigens, the activation and response of the immune system and other immune essence. However, before successfully inducing immune tolerance, how to carry out individualized induction of immune tolerance in organ transplant recipients to optimize the combination of immunosuppressive agents and individualized treatment and achieve the ideal state of optimal prevention and treatment of immune rejection and minimal adverse reactions, remains to be further resolved by the organ transplantation practitioners. Based on the reports of international core journals, the individualized induction strategy of immune tolerance and the future prospects were reviewed in this article from the following aspects including the mechanism underlying induction of immune tolerance, realization of operational immune tolerance, novel strategy of individualized induction of immune tolerance and application of regulatory T cell in individualized immune tolerance in combination with clinical and laboratory research results of regulatory T cell in our center.

     

    • FullText(HTML)
  • loading
    • References(23)
  • [1]
    MOREAU A, VAREY E, ANEGON I, et al. Effector mechanisms of rejection[J]. Cold Spring Harb Perspect Med, 2013, 3(11). DOI: 10.1101/cshperspect.a015461.
    [2]
    KRZYMOWSKI T, STEFAŃCZYK-KRZYMOWSKA S. Advances in understanding the physiological mechanism of maternal immune tolerance to the embryo[J]. Reprod Biol, 2012, 12(3):265-270. DOI: 10.1016/j.repbio.2012.10.004.
    [3]
    SCHIETINGER A, GREENBERG PD. Tolerance and exhaustion: defining mechanisms of T cell dysfunction[J]. Trends Immunol, 2014, 35(2):51-60. DOI: 10.1016/j.it.2013.10.001.
    [4]
    HU B, YANG XB, SANG XT. Liver graft rejection following immune checkpoint inhibitors treatment: a review[J]. Med Oncol, 2019, 36(11):94. DOI: 10.1007/s12032-019-1316-7.
    [5]
    陈瑜, 于姝, 滕飞, 等.自身免疫调节因子与中枢免疫耐受[J].现代免疫学, 2010, 30(1):1-4. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=shmyxzz201001001

    CHEN Y, YU S, TENG F, et al. Autoimmune regulatory factors and central immune tolerance [J]. Curr Immunol, 2010, 30(1):1-4. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=shmyxzz201001001
    [6]
    郑配国, 马攀红, 符含笑, 等.可溶性髓鞘少突胶质细胞糖蛋白(MOG)诱导实验性自身免疫性脑脊髓炎(EAE)小鼠免疫耐受的机制[J].细胞与分子免疫学杂志, 2018, 34(5):414-420. http://d.old.wanfangdata.com.cn/Periodical/xbyfzmyxzz201805006

    ZHENG PG, MA PH, FU HX, et al. Mechanism of immune tolerance induced by soluble myelin oligodendrocyte glycoprotein in mice with experimental autoimmune encephalomyelitis[J]. Chin J Cell Mol Immunol, 2018, 34(5):414-420. http://d.old.wanfangdata.com.cn/Periodical/xbyfzmyxzz201805006
    [7]
    PARAF A, GUéRIN-MARCHAND C, AUBRY J, et al. Mechanism of immune stimulation and tolerance based on an hypothesis on the cell division mechanism directed by the cell membrane[J]. Ann Immunol (Paris), 1975, 126C(4):423-430. http://cn.bing.com/academic/profile?id=efe83146bc89aaf8dd39a35747e11b22&encoded=0&v=paper_preview&mkt=zh-cn
    [8]
    MAKKOUK A, WEINER GJ. Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge[J]. Cancer Res, 2015, 75(1):5-10. DOI: 10.1158/0008-5472.CAN-14-2538.
    [9]
    KOSIEWICZ MM, ALARD P, LIANG S, et al. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand[J]. Int Immunol, 2004, 16(5):697-706. doi: 10.1093/intimm/dxh067
    [10]
    THAPA P, FARBER DL. The role of the thymus in the immune response[J]. Thorac Surg Clin, 2019, 29(2):123-131. DOI: 10.1016/j.thorsurg.2018.12.001.
    [11]
    GEENEN V. History of the thymus: from an "accident of evolution" to the programming of immunological self-tolerance[J]. Med Sci (Paris), 2017, 33(6/7):653-663. DOI: 10.1051/medsci/20173306024.
    [12]
    朱小慧, 盛德乔.免疫耐受机制的研究进展[J].细胞与分子免疫学杂志, 2011, 27(5):121-123. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xbyfzmyxzz201105041

    ZHU XH, SHENG DQ. Research progress of immune tolerance mechanism[J]. Chin J Cell Mol Immunol, 2011, 27(5):121-123. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xbyfzmyxzz201105041
    [13]
    伍仙凤, 盛德乔.外周免疫耐受机制的研究进展[J].免疫学杂志, 2013, 29(8):710-714, 719. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=myxzz201308015

    WU XF, SHENG DQ. Progress in mechanisms of peripheral immunological tolerance[J]. Immunol J, 2013, 29(8):710-714, 719. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=myxzz201308015
    [14]
    BLACK CK, TERMANINI KM, AGUIRRE O, et al. Solid organ transplantation in the 21st century[J]. Ann Transl Med, 2018, 6(20):409. DOI: 10.21037/atm.2018.09.68.
    [15]
    GRUNEBAUM E, AVITZUR Y. Liver-associated immune abnormalities[J]. Autoimmun Rev, 2019, 18(1):15-20. DOI: 10.1016/j.autrev.2018.06.016.
    [16]
    NALESNIK MA, RAO AS, FURUKAWA H, et al. Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients[J]. Transplantation, 1997, 63(9):1200-1205. doi: 10.1097/00007890-199705150-00002
    [17]
    GIRLANDA R, VILCA-MELENDEZ H, SRINIVASAN P, et al. Immunosuppression withdrawal after auxiliary liver transplantation for acute liver failure[J]. Transplant Proc, 2005, 37(4):1720-1721. doi: 10.1016/j.transproceed.2005.03.141
    [18]
    ICHIKAWA T, TAURA N, MIYAAKI H, et al. β-cell function prior to liver transplantation contributes to post-operative diabetes[J]. Biomed Rep, 2016, 5(6):749-757. DOI: 10.3892/br.2016.788.
    [19]
    TZAKIS AG, KATO T, NISHIDA S, et al. Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation[J]. Transplantation, 2003, 75(9):1512-1517. doi: 10.1097/01.TP.0000060250.50591.39
    [20]
    ZENG H, ZHANG R, JIN B, et al. Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance[J]. Cell Mol Immunol, 2015, 12(5):566-571. DOI: 10.1038/cmi.2015.44.
    [21]
    TODO S, YAMASHITA K, GOTO R, et al. A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation[J]. Hepatology, 2016, 64(2):632-643. DOI: 10.1002/hep.28459.
    [22]
    ZWANG NA, LEVENTHAL JR. Cell therapy in kidney transplantation: focus on regulatory T cells[J]. J Am Soc Nephrol, 2017, 28(7):1960-1972. DOI: 10.1681/ASN.2016111206.
    [23]
    SAFINIA N, GRAGEDA N, SCOTTà C, et al. Cell therapy in organ transplantation: our experience on the clinical translation of regulatory T cells[J]. Front Immunol, 2018, 9:354. DOI: 10.3389/fimmu.2018.00354.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (319) PDF downloads(43) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return